DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Poloxamer 188 is an investigational drug.
There have been 5 clinical trials for Poloxamer 188. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2013.
The most common disease conditions in clinical trials are Anemia, Sickle Cell, Peripheral Vascular Diseases, and Peripheral Arterial Disease. The leading clinical trial sponsors are Mast Therapeutics, Inc., CytRx, and Valentis.
Recent Clinical Trials for Poloxamer 188
|Evaluation of Repeat Administration of Purified Poloxamer 188||Mast Therapeutics, Inc.||Phase 3|
|Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)||Mast Therapeutics, Inc.||Phase 3|
|Population Pharmacokinetics/Pharmacodynamics (PK/PD) of Microemulsion Propofol in Healthy Volunteers||Asan Medical Center||Phase 1|